Oyster Point Pharma, Inc. Embedded Derivative, Gain (Loss) on Embedded Derivative, Net
Oyster Point Pharma, Inc. reported Embedded Derivative, Gain (Loss) on Embedded Derivative, Net of -$5.81 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Other Income
us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet · last filed 2022-11-10
- Oyster Point Pharma, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2022-09-30 was $427.00K, a 101.42% increase year-over-year.
- Oyster Point Pharma, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2022-06-30 was -$3.54M.
- Oyster Point Pharma, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2022-03-31 was -$2.69M.
- Oyster Point Pharma, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2021-12-31 was -$526.00K.
- Oyster Point Pharma, Inc. embedded derivative, gain (loss) on embedded derivative, net for fiscal 2021 was -$314.00K.
- Oyster Point Pharma, Inc. embedded derivative, gain (loss) on embedded derivative, net for fiscal 2020 was $0.00.
| Period end | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 3 month | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 6 month | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 9 month | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 12 month |
|---|---|---|---|---|
| 2022-09-30 | $427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$3.12M derived: sum of 2 quarters · filed 2022-11-10 | -$5.81M 10-Q · filed 2022-11-10 | -$6.33M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | -$3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$6.23M 10-Q · filed 2022-08-11 | -$6.76M derived: sum of 3 quarters · filed 2022-08-11 | -$6.55M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-03-31 | -$2.69M 10-Q · filed 2022-05-05 | -$3.22M derived: sum of 2 quarters · filed 2022-05-05 | -$3.00M derived: sum of 3 quarters · filed 2022-11-10 | -$3.00M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-12-31 | -$526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$314.00K derived: sum of 2 quarters · filed 2022-11-10 | -$314.00K derived: sum of 3 quarters · filed 2022-11-10 | -$314.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $212.00K derived: sum of 2 quarters · filed 2022-11-10 | $212.00K 10-Q · filed 2022-11-10 | $212.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 |